Business 646 views on YouTube
Bayer's $7.25 Billion Roundup Settlement: Some Get $10,000.
On Monday 14 September 2026, Judge Timothy Boyer of the Missouri Circuit Court in St. Louis began considering final approval of Bayer's $7.25 billion settlement of Roundup cancer claims. Bayer's Monsanto unit is asking him to sign off.
The deal covers roughly 65,000 lawsuits. Every one makes the same claim: that the weedkiller caused non-Hodgkin lymphoma.
In court, some plaintiffs' attorneys objected, arguing their clients should not be pushed into Bayer's framework. Other attorneys told the judge the opposite: that for their clients, this settlement is the best route left to compensation.
One thing the hearing does not decide: a settlement is not a finding of liability. Nobody in that courtroom was ruling on whether Roundup causes cancer. They were deciding what it costs. That question remains contested in the scientific literature and in the courts, and this reel takes no position on it.
The spine
On Monday 14 September 2026, Judge Timothy Boyer of the Missouri Circuit Court in St. Louis began considering final approval of Bayer's $7.25 billion settlement of Roundup cancer claims. Bayer's Monsanto unit wants it approved to close out tens of thousands of US lawsuits alleging the weedkiller causes non-Hodgkin lymphoma.
The turn is the arithmetic: $7.25 billion across roughly 65,000 claims, paid on a scale of $10,000 to $165,000 per claimant.
The numbers
- $7.25 billion — the total.
- ~65,000 lawsuits covered.
- $10,000 to $165,000 per claimant, scaled to cancer severity, age at diagnosis and exposure history.
- The claim in every one of them: Roundup caused non-Hodgkin lymphoma.
What happened in court
- The hearing was held Monday 14 September 2026 before Judge Timothy Boyer.
- He heard objections from some plaintiffs' attorneys, who argued their clients should not be pushed into Bayer's framework.
- He also heard from lawyers who said the settlement is the best way for their clients to be compensated.
- He was not expected to rule at the hearing.
How this was verified — the rest of the fact sheet
Why Bayer wants it
The settlement is designed to limit Bayer's future liability — to draw a line under the litigation it inherited when it bought Monsanto. That is the objecting lawyers' complaint in one sentence: a line drawn cheaply.
Sources
- Claims Journal, "Bayer Faces Test of $7.25B Roundup Settlement In Missouri Court", 14 September 2026.
- The Epoch Times, "Judge to Begin Consideration of Bayer's $7.25 Billion Roundup Settlement", 14 September 2026.
- Genetic Literacy Project, 14 September 2026.
- C&EN, "Bayer's $7.25 billion Roundup class settlement advances", March 2026.
References
Reporting drawn from Claims Journal · The Epoch Times · Genetic Literacy Project · C&EN
What the reel says
Narration as scripted and voiced.
A courtroom in St. Louis spent Monday on a number, seven point two five billion dollars. That is what Bayer wants to pay to end the Roundup cancer lawsuits, all of them at once
Judge Timothy Boyer of the Missouri Circuit Court began considering final approval. Bayer's Monsanto unit is asking him to sign off on it
The deal covers about 65,000 lawsuits. Every one of them makes the same claim, that the weed killer caused non-Hodgkin lymphoma
Now do the division. The payments run from ten thousand dollars to a hundred and sixty-five thousand, scaled by how severe the cancer was, how old you were, and how much you were exposed
Some lawyers for the plaintiffs stood up to object. They told the judge their clients should not be pushed into Baier's framework at all
Other lawyers told him the opposite, that for their clients, this settlement is the best way left to be compensated
What Bayer gets is a line under the thing it bought. It acquired Monsanto and it inherited the litigation. This deal is built to limit what comes after
Boyer was not expected to rule on Monday. He heard the objections, he heard the support, and he took it away
One thing this does not settle. A settlement is not a finding. Nobody in that room decided whether Roundup causes cancer. They were deciding what it costs
All footage is licensed stock. No Bayer or Monsanto branding, no product packaging, no courtroom footage and no identifiable patients.
